1Schiedner G;Morral N;Parks RJ.Genomic DNA transfer with a highcapacity adenovirus vector results in improved in vivo gene expression and decreased toxicity,1998.
2Lieber A;He CY;Kirillova I.Recombinant adenoviruses with large deletions generated by remediated ecision exhibit different biological properties compared with first-generation vectors in vitro and in vivo,1996.
3Hehir KM;Armentano D;Cardoza LM.Molecular characterization of replication competent variants of adenovirus vectors and genome modifications to prevent their occurence,1996.
4Zoltick PW;Chirmule N;Schnell MA.Biology of E1-deleted adenovirus vectors in nonhuman primate muscle[J],2001.
5Stephan A;Vorburger Kelly K.Adenoviral Gene Therapy[J],2002(1).
6Ganly I;Kim D;Eckhardt G.A phase Ⅰ study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer,2000(03).
7James RB;David K;Angelica W.An andnovirus mutant that replicates selectively in p53-deficient human tumor cells,1997(5286).
8Barker DD;Berk AJ.Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection[J],1987(01).
9Raper S E;Haskal Z J;Ye X.Selective gene transfer into the liver of non-human primates with E1-deleted, E2A-defective, or E1-E4 deleted recombinant adenoviruses,1998(05).
10Gorsiglia M I;Lapcevich C;Roy S.Generation of an adenovirus vector lacking E1 ,e2a,E3 ,and all of E4 except open reading frame 3,1999(07).
